Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Roldano Fossati"'
Autor:
Nicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, Maria Ornella Nicoletto, Germana Tognon, Alessandra Bologna, Andrea Alberto Lissoni, Andrea DeCensi, Mariateresa Lapresa, Rosanna Mancari, Innocenza Palaia, Giulia Tasca, Francesca Tettamanzi, Maria Francesca Alvisi, Eliana Rulli, Davide Poli, Luciano Carlucci, Valter Torri, Roldano Fossati, Elena Biagioli
Background: Previous findings showed that cediranib-olaparib increased PFS in women with recurrent platinum-sensitive ovarian cancer compared to olaparib alone. Methods: BAROCCO trial randomized 123 patients: 80 mg/m2 paclitaxel weekly up to 24 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50894eb2b17531be40c0f3ed8a7a185
http://hdl.handle.net/11573/1643684
http://hdl.handle.net/11573/1643684
Autor:
Carien L. Creutzberg, Petronella B. Ottevanger, Annamaria Ferrero, Luis Souhami, Pearly Khaw, GH Westerveld, Diane Provencher, Gillian Thomas, Jan Pyman, V. Do, Annerie Slot, C Davidson, G. Wilson, Stephanie M. de Boer, Peter Hoskin, C M McLachlin, Michael A. Quinn, Deborah Gregory, Remi A. Nout, Hans W. Nijman, J.J. Jobsen, Tanja C. Stam, Vincent T.H.B.M. Smit, K Whitmarsh, Paul Bessette, Roy F.P.M. Kruitwagen, W Taylor, Dionyssios Katsaros, Chantal Hanzen, Henry C Kitchener, M McCormack, Prafull Ghatage, Dominique Berton-Rigaud, J.W.M. Mens, Melanie E Powell, Elisabeth Pras, Jonathan A. Ledermann, Karen W Verhoeven-Adema, Harmen Hollema, Andrea Lissoni, Linda Mileshkin, Anjana Anand, Amanda Feeney, Sergio Gribaudo, Marie-Helene Baron, R Allerton, Hein Putter, Colin D. Johnson, P. Symonds, Ina M. Jürgenliemk-Schulz, Romerai D'Amico, Ilka Kolodziej, M Adusumalli, Naveena Singh, G Artioli, An Snyers, R Wade, Christine Haie-Meder, Roldano Fossati, Nicole Tubiana-Mathieu, Anthony Fyles, Silvestro Carinelli, Anne Capp, Alexandra J. Stewart, Kaj De Winter, B. van Triest, L.C.H.W. Lutgens, Susan Brooks, E. Van der Steen-Banasik, Pierre Duvillard, Pvc Rittenberg, Alessandro Colombo
Publikováno v:
Lancet Oncology, 20, 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
BACKGROUND:The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and
Autor:
Ina M. Jürgenliemk-Schulz, Ludy C.H.W. Lutgens, Marie Helene Baron, V. Do, Karen W Verhoeven-Adema, C. Post, Nelleke Ottevanger, Carien L. Creutzberg, Christine Haie-Meder, Jonathan A. Ledermann, Susan Brooks, Geraldine Goss, Linda Mileshkin, Anthony Fyles, Paul Bessette, Melanie E Powell, Roldano Fossati, Mary McCormack, Stephanie M. de Boer, Henry C Kitchener, Andrea Lissoni, Alexandra Leary, Vincent T.H.B.M. Smit, Romerai D'Amico, Amanda Feeney, Dionyssios Katsaros, Remi A. Nout, Hans W. Nijman, Hein Putter, Prafull Ghatage, Pearly Khaw
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
Contains fulltext : 232064.pdf (Publisher’s version ) (Open Access) PURPOSE: The survival results of the PORTEC-3 trial showed a significant improvement in both overall and failure-free survival with chemoradiation therapy versus pelvic radiation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2798f409593ab83be7f21b7d7f100a58
http://www.redjournal.org/article/S0360301620344473/pdf
http://www.redjournal.org/article/S0360301620344473/pdf
Autor:
Roldano Fossati, Ignace Vergote, Bradley J. Monk, Larry J. Copeland, Robert L. Coleman, Jalid Sehouli, David M. O'Malley
Publikováno v:
Trials in progress abstract.
Introduction/Background Tumor Treating Fields (TTFields) are a non-invasive, antimitotic cancer therapy. The Phase 2 INNOVATE study demonstrated safety of TTFields/weekly paclitaxel in 31 PROC (platinum-resistant ovarian cancer) patients (Vergote Gyn
Autor:
Rosalind Glasspool, Jean-Emmanuel Kurtz, Val Gebski, Anne-Sophie Darlington, Jonathan S. Berek, Effi Yeoshoua, Aleksandra Strojna, Iwa Kong, Laura Farrelly, Orgad Rosenblat, Vladyslav Sukhin, Michael Friedlander, Roldano Fossati, Mariana de Paiva Batista, Phillip Harter, Mark Carey, Ting-Chang Chang, Rahul Roy Chowdhury, Sandra Polleis, Marcia Hall, Chyong-Huey Lai, Byung-Ho Nam, Jung Yun Lee, Richard Schwameis, Patricia Roxburgh, Noriko Fujiwara, Jae Weon Kim, Alexi A. Wright, Xavier Paoletti
Publikováno v:
Gynecologic oncology. 161(2)
Background Quality of life and patient reported outcome measures (PROMs) are important secondary endpoints and incorporated in most contemporary clinical trials. There have been deficiencies in their assessment and reporting in ovarian cancer clinica
Autor:
Simona Frezzini, Eleonora Zaccarelli, Davide Poli, Giovanni Scambia, Roldano Fossati, E. Negri, Valter Torri, Andrea Lissoni, Nicoletta Colombo, Chiara Gerardi, Francesca Galli, Alessandra Baldoni, Germana Tognon, Gabriella Farina, Eleonora Palluzzi, Elena Biagioli, Angela Pesenti Gritti, Eliana Rulli, Maurizio D'Incalci, Daniela Rubino, Annamaria Ferrero
Publikováno v:
British Journal of Cancer
Background Trabectedin, in addition to its antiproliferative effect, can modify the tumour microenvironment and this could be synergistic with bevacizumab. The efficacy and safety of trabectedin and bevacizumab ± carboplatin have never been investig
Autor:
Giovanni Apolone, A. Zaniboni, Gianfranco Pavia, R. Labianca, Bruno Andreoni, N. Pinna, Frank E. Johnson, Eva Negri, Gianfranco Pancera, Gerardo Rosati, Sandro Barni, Pietro Sozzi, Roldano Fossati, Valter Torri, G. Solina, Paola Mosconi, G. Ambrosini, F. Gaion, G. Corradini, G. Martignoni, Giovanna Luchena, Sandro Pignata, Bruno Daniele, Marta Monteforte, M. Duro, Giovanni Oliverio
Publikováno v:
Annals of Oncology. 27:274-280
Background Colorectal cancer is the third most common and the third most lethal cancer in both men and women in developed countries. About 75% of cases are first diagnosed when the disease is classified as localized or regional, undergo potentially c
Autor:
Roldano Fossati, J. Maenpaa, Germana Tognon, Angiolo Gadducci, C. Churruca Galaz, A. De Censi, Elena Biagioli, Andres Poveda, Radoslav Chekerov, Eliana Rulli, Ignace Vergote, Ana Montes, G-B. Nyvang, AG Zeimet, Nicoletta Colombo, Alessandra Baldoni, Nelleke Ottevanger, G. Funari, Jalid Sehouli, S. Riniker
Publikováno v:
Annals of Oncology. 31:S1161
Autor:
Christian Marth, Elena Biagioli, M. Rabaglio, Frederik Marmé, Nicoletta Colombo, Emma Hudson, Angeles Alvarez Secord, F. Tettamanzi, Roldano Fossati, Kenichi Harano, Anna Roberto, Y. Antill, M.P. Barretina Ginesta
Publikováno v:
Annals of Oncology. 31:S647
Autor:
Maurizio D'Incalci, Giovanni Scambia, Angela Buonadonna, Roldano Fossati, Nicoletta Colombo, E. Negri, Elena Biagioli, Francesco Raspagliesi, Francesca Galli, Eliana Rulli, Roberta Sanfilippo, Armando Santoro, Milena Bruzzone, G. Artioli, Giovanni Grignani, Paolo G. Casali, Valter Torri, Federica Grosso, Angiolo Gadducci, Domenica Lorusso
Publikováno v:
British Journal of Cancer
Background: Patients with recurrent/metastatic uterine leiomyosarcoma (U-LMS) have a dismal prognosis. This phase II study aims to evaluate trabectedin efficacy and safety in advanced U-LMS. Methods: Eligible patients had received ≥ one line of che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cc6648a602836997a79332b7f96811b
http://hdl.handle.net/11568/948091
http://hdl.handle.net/11568/948091